Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…
Invectys Inc. to participate in the 2021 Roth Virtual Healthcare Private Company Forum on June 28th, 2021 Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) –…
Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 1st, 2021 (GLOBE NEWSWIRE) — Invectys…
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…
AACR Annual Meeting 2021 April 10th – 15th 2021 Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…
Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …
Invectys reports in vivo efficacy of its pan anti-tumor anti-HLA-G CAR-T cells These results open new perspectives in oncology for targeting cancer through HLA-G,…
Invectys Strengthens Advisory Board with the Appointment of Dennis J. Purcell, Life Sciences Industry Veteran and Founder of Aisling Capital LLC Paris, France, May…
